We're #hiring a new Research Associate, Stem Cell Biology in Cambridge, Massachusetts. Apply today or share this post with your network.
关于我们
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells? by tailoring cells for specific diseases. The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.
- 网站
-
https://www.gc-tx.com
GC Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Cambridge,MA
- 类型
- 私人持股
地点
-
主要
US,MA,Cambridge
GC Therapeutics员工
动态
-
We’re excited to announce our CEO and Co-Founder, Parastoo Khoshakhlagh, Ph.D., will be co-hosting the Boston leg of The Founder-Led Biotech Tour hosted by Pillar VC in Cambridge on Wednesday, November 20th! She will be joined by fellow top biotech founders and industry leaders - we hope you can join us to connect with these pioneers and be inspired by the movement. For more details:?https://lnkd.in/gWhS5_4Y Special thanks to Thomas de Vlaam and Tony Kulesa for making this evening of networking and insights possible! #PillarVC #CambridgeMA #BostonEvents #Biotech #FounderLedBiotech #Networking #Innovation #BiotechLeaders #GCTx
-
We're #hiring a new Research Associate - Molecular Biology in Cambridge, Massachusetts. Apply today or share this post with your network.
-
We’re excited to share that our CEO,?Parastoo Khoshakhlagh, Ph.D., a 2023 Termeer Fellow will be a featured panelist at an upcoming discussion on female leaders in biotech hosted by The Termeer Foundation and WEST - Women in the Enterprise of Science and Technology. This panel will explore the unique experiences, challenges, and successes of women stepping into leadership roles as executives and founders in the biotech industry. Parastoo will be joined by fellow inspiring female leaders Vered Bisker-Leib, Nele Van Dessel (Termeer Fellow), and Jo Viney. Special thanks to Rachele Ryan, Director of Partnerships at LabCentral for moderating! ?? Date: November 6, 2024 ?? Time: 8:00-10:00 AM ET ?? Location: The Termeer Foundation, 1393 Boylston St., Boston, MA 02215 ?? Learn more and register at?https://lnkd.in/gUSNvzcm Join us for an empowering conversation that aims to uplift and celebrate women making waves in the world of biotech!
-
Thrilled to have attended BioFuture for the third consecutive year! Last week, at the Cure. in New York City, #BioFuture 2024 gathered a remarkable community of trailblazers, disruptors, and investors from across the healthcare ecosystem to discuss the future of healthcare innovation. The conference spotlighted impactful discussions on AI/ML, quantum computing, policy advancements, neuroscience, oncology, obesity treatments, longevity, biomanufacturing, cell and gene therapy, cardiovascular health, women’s health, and financing strategies. We explored the convergence of deep tech and deep science in drug discovery & development, diving into the forefront of healthcare transformation. It was also the perfect opportunity to reconnect with fellow investors, founders, and ecosystem partners. Great to finally meet Parastoo Khoshakhlagh, Ph.D. in person and catch up with Tingting Zhang-Kharas, PhD, Silvia Garcia Codony, and Lynda Chin. A huge thanks to Sara Jane Demy and Demy-Colton for organizing such an inspiring event. Already looking forward to BioFuture 2025! #healthcare #biotech #lifescience #biopharma #TechBio #AI #Therapeutics #venturecapital #innovations #deeptech
-
Proud to announce that our CEO Parastoo Khoshakhlagh, Ph.D. will be speaking on the panel Emerging Technologies and Approaches in Cell & Gene Therapy at #BioFuture2024! With the field evolving at an incredible pace, emerging technologies like AI and machine learning are reshaping what we can achieve. She will be joined by Paul Bresge, Kate Rochlin, PhD and moderator Lei Lei Wu to discuss how these innovations are breaking through current limitations, enhancing precision, and speeding up the journey from research to real-world applications. Together, we're making strides toward more effective, accessible therapies that have the power to transform lives. Special thank you to Sara Jane Demy, Sara Pinto, and Kimberly Ha for the invitation and opportunity contribute to the discussion and explore the latest topics shaping the future of #healthcare. Join us for insightful conversations driving the next wave of breakthrough innovation. Register at?www.BioFuture.com!
-
Will you be attending the 5th Cell Therapies and Immunotherapy Conference in San Diego hosted by AIChE - American Institute of Chemical Engineers? If you are, be sure to check out our company presentation with Dr. Cory Smith, our Head of Discovery Platforms & Scientific Co-Founder, on October 28th from 3:20-4:10pm?PT during the Poster Lightning Talks session! For more info: https://bit.ly/3YJnBtC
-
We're #hiring a new Scientist/Senior Scientist - Computational Biologist in Cambridge, Massachusetts. Apply today or share this post with your network.
-
Our CEO?Parastoo Khoshakhlagh, Ph.D. is grateful to have had the opportunity to join the 2024 Precision Health Summit and speak on a panel about Ensuring Equitable Access to Precision Regenerative Medicine. It was a pleasure to connect with such a talented group of professionals, including Dr. Peter Marks, Dr.?Brigitte Arduini, and?Willie T. Reaves Jr.?and to be given the platform to share these insights. Thank you to 1BusinessWorld , the organizers, fellow panelists, and everyone who attended! We are looking forward to more opportunities to engage and learn together.
We extend our deepest gratitude to all the visionary leaders who contributed to the success of the 2024 Precision Health Summit. Your insights, expertise, and commitment have made this gathering a transformative moment in the journey toward advancing personalized medicine and precision health. A heartfelt thank you to Ali Mostashari, Peter Marks, Joshua Di Frances, Willie T. Reaves, Raya Khanin, Poroshat Shekarloo, Arda Ural, Alfredo Carvajal, Simon Sakhai, Amrie Grammer, Dr. D. Martin Alexander Gershon, Asieh Golozar, Nicole Avena, Parastoo Khoshakhlagh, Brigitte Arduini, Allan Gobbs, Arash Kia, Mario Storga, Gabriele Allegri, Matthias Wagner, Aquil Harjivan, Fern Lazar, Christina Kotsi, Sarah Pesce, Pooja Majmudar, and Tony Reid. Your contributions are shaping the future of healthcare, driving innovation, and improving patient outcomes worldwide. Your expertise and dedication are driving the global evolution of precision health, ensuring a brighter future for healthcare worldwide. Thank you for your leadership and vision. #precisionhealth #personalizedmedicine #health #healthcare #healthtech #medicine #lifesciences #biotech #healthai #healthdata LifeNome Inc. LG Electronics LG NOVA Cellino 1BusinessWorld Bayer Johnson & Johnson Innovative Medicine Thorne FINN Partners EY Maimonides Medical Center Mount Sinai Health System Icahn School of Medicine at Mount Sinai Endeavor Venture Fund and Venture Studio Odysseus Data Services GC Therapeutics ATEM Capital
-
+2
-
Our mission at GC Therapeutics is rooted in the grand vision of our co-founder and advisor, Prof. George Church: creating higher-quality cell therapies that are accessible to all patients. This mission aligns closely with Henri Termeer’s legacy. We are dedicated to fulfilling our responsibility as a biotech company, as Henri described—to tackle what seems impossible and make a real difference for patients. As a #Termeer Fellow I am grateful for the opportunity to work alongside mentors and colleagues who share the same passion as we do at GC Therapeutics. This collective support has significantly helped me do my job better. I am incredibly proud and thankful to be part of this amazing community!